跳至主要内容
临床试验/NCT00182507
NCT00182507已完成4 期

A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania

Hamilton Health Sciences Corporation2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2000年6月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
34
试验地点
2
主要终点
Clinical Global Impression (CGI)-Improvement Scale ≤ 2

研究概览

简要总结

Trichotillomania (TTM) or hair-pulling has been considered as part of the obsessive compulsive disorder (OCD) spectrum, although treatment with OCD medications has largely been unsuccessful. Tics/Tourrettes' Syndrome (TS) is a disorder, which appears to be related to TTM, but is treated with a different class of medications than used in OCD, namely antipsychotics such as olanzapine. This is a study of the safety and efficacy of olanzapine in the treatment of hair pulling.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • primary DSM-IV trichotillomania; CGI-Severity ≥ 4

排除标准

  • Any other Axis I primary diagnosis; CGI-S < 4; current comorbid: OCD, MDD, alcohol or substance abuse; lifetime hx of: schizophrenia, bipolar affective disorder or dementia; current pregnancy/lactation; current suicidality or homicidality; major medical problems or clinically unstable medical disease; hx of: seizures, stroke or head trauma; prior use of neuroleptics

结局指标

主要结局

Clinical Global Impression (CGI)-Improvement Scale ≤ 2

次要结局

  • CGI-Severity Scale, Mean change from baseline in: Yale-Brown Obsessive Compulsive Scale for TTM, the Massachusetts General Hospital Hair Pulling Scale

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Olanzapine in the Treatment of Hair Pulling... | 临床试验